Why Are UnitedHealth Group and Bristol-Myers Squibb Attracting Hedge Funds

Related Articles

Why Are Barclays Analysts Bullish on Eli Lilly and Bristol-Myers Squibb

5 months ago

Why is Barclays Bullish on Bristol-Myers Squibb (BMY) Now

5 months ago

Is Bristol Myers Squibb's New Multiple Myeloma Drug a Game Changer

6 months ago

Is Bristol Myers Squibb's Deucravacitinib a Game-Changer for SLE Patients and BMY Investors

3 months ago

Category

You may also like

Stock News•6 days ago

Hedge Funds Split on Amazon After a Big Q2 Rotation

Amazon's Q2 report shows hedge funds split sharply on AMZN, with major funds taking opposing positions after a big rotation. The split reflects divergent views on valuation and growth prospects.

AMZN

Share

Stock News•4 weeks ago

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

UnitedHealth pulled back from a 52-week high after earnings, as stronger guidance offset Medicaid headwinds, spotlighting healthcare ETFs with sizable exposure.

UNH

Share

Stock News•1 months ago

The Boldest Bets on Wall Street Right Now Are in the Same Handful of Stocks

Q1 2026 13F filings show hedge funds crowding into the same mega-cap stocks, with concentrated portfolios revealed by the May 15 filing deadline.

GOOGL

Share

Stock News•1 months ago

Investors Are Rotating Into Healthcare. Here's Why.

Healthcare sector attracts investor rotation as innovation in biotech, pharma, and medical devices proliferates, per Janus Henderson portfolio manager Dan Lyons.

BBH

Share